Steven J Chmura Selected Research

pembrolizumab

1/2022	Evaluation of Dose Distribution to Organs-at-Risk in a Prospective Phase 1 Trial of Pembrolizumab and Multisite Stereotactic Body Radiation Therapy (SBRT).
12/2020	Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial.
1/2020	A Validated T Cell Radiomics Score Is Associated With Clinical Outcomes Following Multisite SBRT and Pembrolizumab.
1/2019	Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab.
1/2018	Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven J Chmura Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 02/2003
22	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2006
11	Breast Neoplasms (Breast Cancer) 12/2020 - 02/2005
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 06/2010
4	Head and Neck Neoplasms (Head and Neck Cancer) 05/2006 - 02/2003
3	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2014
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 03/2012
3	Anus Neoplasms (Anal Cancer) 11/2009 - 10/2005
2	Pneumonia (Pneumonitis) 11/2022 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2007 - 10/2005
1	Disease Progression 01/2022
1	Glioma (Gliomas) 12/2021
1	Anetoderma 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Bites and Stings (Sting) 01/2021
1	Infections 07/2020
1	COVID-19 07/2020
1	Gliosarcoma 01/2020
1	Fatigue 01/2020
1	Neurobehavioral Manifestations 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2020
1	Mediastinal Diseases 01/2019
1	Merkel Cell Carcinoma 01/2019
1	Astrocytoma (Pilocytic Astrocytoma) 09/2018
1	Multiple Myeloma 11/2017
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	AIDS-Related Complex (ARC) 01/2017
1	Necrosis 04/2014
1	Pituitary Neoplasms (Pituitary Adenoma) 09/2006
1	Squamous Cell Carcinoma of Head and Neck 02/2006
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2004
1	Primitive Neuroectodermal Tumors (PNET) 06/2004
1	Cholangiocarcinoma 06/2004

Drug/Important Bio-Agent (IBA)

5	pembrolizumabIBA 01/2022 - 01/2018
5	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2018
4	Biological ProductsIBA 01/2019 - 01/2011
4	MicroRNAs (MicroRNA)IBA 06/2016 - 01/2011
3	Temozolomide (Temodar)FDA LinkGeneric 12/2021 - 03/2012
3	Bevacizumab (Avastin)FDA Link 12/2021 - 04/2014
2	NivolumabIBA 01/2022 - 10/2021
2	InterferonsIBA 01/2021 - 01/2018
2	B7-H1 AntigenIBA 01/2021 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 04/2014
2	Contrast MediaIBA 10/2010 - 08/2010
2	Deoxyglucose (2 Deoxy D glucose)IBA 10/2010 - 08/2010
2	GoldIBA 10/2010 - 08/2010
1	IpilimumabIBA 01/2022
1	urelumabIBA 10/2021
1	cabiralizumabIBA 10/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	trebananibIBA 01/2020
1	Memantine (Namenda)FDA Link 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	LigandsIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Blocking AntibodiesIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	CytokinesIBA 01/2018
1	SilverIBA 05/2017
1	veliparibIBA 01/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016
1	Monoclonal AntibodiesIBA 04/2014
1	bistratene AIBA 06/2010
1	Actins (F Actin)IBA 06/2010
1	phytobacteriomycin (PBM)IBA 04/2008
1	Ifosfamide FDA LinkGeneric 06/2004
1	Etoposide (VP 16)FDA LinkGeneric 06/2004

Therapy/Procedure

35	Radiotherapy 11/2022 - 10/2005
25	Therapeutics 01/2022 - 12/2004
9	Drug Therapy (Chemotherapy) 01/2019 - 12/2004
5	Immunotherapy 11/2022 - 01/2019
4	Re-Irradiation 12/2021 - 02/2003
4	Segmental Mastectomy (Lumpectomy) 01/2017 - 02/2005
2	Image-Guided Radiotherapy 10/2013 - 02/2012
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 04/2008 - 06/2004
1	Drug Tapering 01/2022
1	Salvage Therapy 12/2021
1	Particle Accelerators 03/2021
1	Radioimmunotherapy 01/2021
1	Conformal Radiotherapy 12/2020
1	Aftercare (After-Treatment) 11/2018
1	Craniospinal Irradiation 11/2017
1	Proton Therapy 11/2017
1	Animal Assisted Therapy 12/2012
1	Chemoradiotherapy 04/2008
1	Overlapping Surgery 02/2006
1	Mastectomy (Mammectomy) 02/2005